These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 6265032)

  • 21. Effects of para-chlorophenylalanine on amphetamine and haloperidol-induced changes in striatal dopamine turnover.
    Kuczenski R
    Brain Res; 1979 Mar; 164():217-25. PubMed ID: 154937
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Systemic administration of thyrotropin-releasing hormone enhances striatal dopamine release in vivo.
    Kreutz MR; Acworth IN; Lehnert H; Wurtman RJ
    Brain Res; 1990 Dec; 536(1-2):347-52. PubMed ID: 1707722
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Influence of thyrotropin-releasing hormone on general behavior and striatal [3H]spiperone binding in developing rats.
    Oki K; Kinoshita Y; Nomura Y; Segawa T
    J Pharmacobiodyn; 1983 Sep; 6(9):607-12. PubMed ID: 6418875
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The transport and turnover of phospholipids in the rat nigrostriatal system: effects of d-amphetamine and haloperidol.
    Hitzemann R; Loh H
    Res Commun Chem Pathol Pharmacol; 1982 Feb; 35(2):209-28. PubMed ID: 6122239
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Modulation of striatal enkephalinergic neurons by antipsychotic drugs.
    Hong JS; Yoshikawa K; Kanamatsu T; Sabol SL
    Fed Proc; 1985 Jun; 44(9):2535-9. PubMed ID: 3838946
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Regulation of neurotensin-containing neurons in the rat striatum and substantia nigra. Effects of unilateral nigral lesion with 6-hydroxydopamine on neurotensin content and its binding site density.
    Masuo Y; Pélaprat D; Montagne MN; Scherman D; Rostène W
    Brain Res; 1990 Mar; 510(2):203-10. PubMed ID: 1970504
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunohistochemical characterization of thyrotropin-releasing hormone-containing neurons in rat septum.
    Ishikawa K; Inoue K; Tosaka H; Shimada O; Suzuki M
    Neuroendocrinology; 1984 Nov; 39(5):448-52. PubMed ID: 6440043
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of various drugs on thyrotropin secretion in rats.
    Mitsuma T; Nogimori T
    Horm Metab Res; 1985 Jul; 17(7):337-41. PubMed ID: 3161812
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Specificity of dopaminergic neuronal degeneration induced by intracerebral injection of 6-hydroxydopamine in the nigrostriatal dopamine system.
    Javoy F; Sotelo C; Herbet A; Agid Y
    Brain Res; 1976 Feb; 102(2):201-15. PubMed ID: 1247882
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of hypophysectomy on pro-thyrotropin-releasing hormone concentrations in rats.
    Mitsuma T; Hirooka Y; Kimura M; Nogimori T
    Exp Clin Endocrinol; 1991 Mar; 97(1):45-9. PubMed ID: 1907564
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of TRH and PS-24 on colonic temperature and motor activity of rats: possible role of dopamine.
    Yehuda S; Youdim MB
    Peptides; 1981; 2(2):131-5. PubMed ID: 6794010
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Modulation of methylenedioxymethamphetamine-induced striatal dopamine release by the interaction between serotonin and gamma-aminobutyric acid in the substantia nigra.
    Yamamoto BK; Nash JF; Gudelsky GA
    J Pharmacol Exp Ther; 1995 Jun; 273(3):1063-70. PubMed ID: 7791076
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Beta-casomorphin inhibits thyrotropin secretion in rats.
    Mitsuma T; Nogimori T; Chaya M
    Exp Clin Endocrinol; 1984 Dec; 84(3):324-30. PubMed ID: 6441729
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Analysis of the mechanism of d-amphetamine-and apomorphine-induced changes of ascorbic acid catabolism in discrete brain areas of the rat.
    Desole MS; Miele M; Esposito G; Enrico P; De Natale G; Miele E
    Pharmacol Res; 1991 Apr; 23(3):295-306. PubMed ID: 2068053
    [TBL] [Abstract][Full Text] [Related]  

  • 35. TRH immunoreactivity in rat brain regions, spinal cord and pancreas: validation by high-pressure liquid chromatography and thin-layer chromatography.
    Spindel E; Wurtman RJ
    Brain Res; 1980 Nov; 201(2):279-88. PubMed ID: 6774800
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Is a dopaminergic system involved in thyrotropin releasing hormone induced hyperthermia and in its potentiation by amphetamine?
    Rips R; Desiles M; Puech AJ
    Prog Neuropsychopharmacol; 1979; 3(4):337-44. PubMed ID: 45568
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Brain thyrotropin-releasing hormone matures independently of the hypothalamus in the rat.
    Mori M; Kobayashi I; Wilber JF
    Horm Metab Res; 1985 Apr; 17(4):181-3. PubMed ID: 3924809
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of melanostatin and thyroliberin on the biosynthesis and release of dopamine by rat brain striatal P2 fractions.
    Shapiro LM; Bowes GM; Vaughan PF
    Life Sci; 1980 Dec; 27(22):2099-108. PubMed ID: 6111009
    [No Abstract]   [Full Text] [Related]  

  • 39. Head turning induced by unilateral intracaudate thyrotropin-releasing hormone (TRH) injection in the cat.
    Malouin F; Bédard PJ
    Eur J Pharmacol; 1982 Jul; 81(4):559-67. PubMed ID: 6811294
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Benzodiazepine interactions with central thyroid-releasing hormone binding sites: characterization and physiological significance.
    Rinehart RK; Barbaz B; Iyengar S; Ambrose F; Steel DJ; Neale RF; Petrack B; Bittiger H; Wood PL; Williams M
    J Pharmacol Exp Ther; 1986 Jul; 238(1):178-85. PubMed ID: 3014114
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.